Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1356642rdf:typepubmed:Citationlld:pubmed
pubmed-article:1356642lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:1356642lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:1356642lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:1356642lifeskim:mentionsumls-concept:C0205464lld:lifeskim
pubmed-article:1356642lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:1356642lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:1356642lifeskim:mentionsumls-concept:C0053169lld:lifeskim
pubmed-article:1356642lifeskim:mentionsumls-concept:C0243072lld:lifeskim
pubmed-article:1356642pubmed:issue6lld:pubmed
pubmed-article:1356642pubmed:dateCreated1992-11-4lld:pubmed
pubmed-article:1356642pubmed:abstractTextTo find a novel alpha-blocker with high alpha-blocking selectivity against dopamine D2-receptor affinity, we performed structural modification of the alkylene chains and the substituents on two benzene rings of 2-alkoxy-5-[(phenoxyalkylamino)alkyl]benzenesulfonamide derivatives. The modification of the alkylene chain between the amino moiety in the center of the molecule and the benzene ring (ring A) was found to be the most significant. 5-[2-[[2-(5-Fluoro-2-methoxyphenoxy)ethyl]amino]propyl]-2- methoxybenzenesulfonamide (II-4), which possesses 1-methylethyl as the alkylene chain, exhibited high alpha-blocking selectivity as well as potent alpha-blocking activity.lld:pubmed
pubmed-article:1356642pubmed:languageenglld:pubmed
pubmed-article:1356642pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1356642pubmed:citationSubsetIMlld:pubmed
pubmed-article:1356642pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1356642pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1356642pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1356642pubmed:statusMEDLINElld:pubmed
pubmed-article:1356642pubmed:monthJunlld:pubmed
pubmed-article:1356642pubmed:issn0009-2363lld:pubmed
pubmed-article:1356642pubmed:authorpubmed-author:ItoYYlld:pubmed
pubmed-article:1356642pubmed:authorpubmed-author:HashimotoSSlld:pubmed
pubmed-article:1356642pubmed:authorpubmed-author:KatzEElld:pubmed
pubmed-article:1356642pubmed:authorpubmed-author:SakuraiSSlld:pubmed
pubmed-article:1356642pubmed:authorpubmed-author:YasudaSSlld:pubmed
pubmed-article:1356642pubmed:authorpubmed-author:MorikawaKKlld:pubmed
pubmed-article:1356642pubmed:authorpubmed-author:MitaniKKlld:pubmed
pubmed-article:1356642pubmed:authorpubmed-author:KoshinakaEElld:pubmed
pubmed-article:1356642pubmed:issnTypePrintlld:pubmed
pubmed-article:1356642pubmed:volume40lld:pubmed
pubmed-article:1356642pubmed:ownerNLMlld:pubmed
pubmed-article:1356642pubmed:authorsCompleteYlld:pubmed
pubmed-article:1356642pubmed:pagination1443-51lld:pubmed
pubmed-article:1356642pubmed:dateRevised2000-12-18lld:pubmed
pubmed-article:1356642pubmed:meshHeadingpubmed-meshheading:1356642-...lld:pubmed
pubmed-article:1356642pubmed:meshHeadingpubmed-meshheading:1356642-...lld:pubmed
pubmed-article:1356642pubmed:meshHeadingpubmed-meshheading:1356642-...lld:pubmed
pubmed-article:1356642pubmed:meshHeadingpubmed-meshheading:1356642-...lld:pubmed
pubmed-article:1356642pubmed:year1992lld:pubmed
pubmed-article:1356642pubmed:articleTitleNovel phenoxyalkylamine derivatives. VII. Synthesis and pharmacological activities of 2-alkoxy-5-[(phenoxyalkylamino)alkyl]benzenesulfonamide derivatives.lld:pubmed
pubmed-article:1356642pubmed:affiliationCentral Research Laboratory, Hokuriku Seiyaku Co., Ltd., Fukui, Japan.lld:pubmed
pubmed-article:1356642pubmed:publicationTypeJournal Articlelld:pubmed